Keywords: Actavis, Bioton, Joint ventre, Insulin development and registration

New Actavis/Bioton alliance aims to shake up diabetes market

Article | 31 January 2012

Print This

Icelandic generics drugmaker Actavis and Poland’s Bioton (WSE: BIO) have formed a joint venture company for the development ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in